(Q41413160)

30 September 2017

1 reference

title

Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies (English)

1 reference

30 September 2017

4

Fauci AS

1 reference

30 September 2017

2

Pantaleo G

1 reference

30 September 2017

Cohen OJ

1

1 reference

PubMed ID

9089951

30 September 2017

Lam GK

series ordinal

3

1 reference

30 September 2017

1 January 1997

1 reference

Seminars in Immunopathology

30 September 2017

1 reference

30 September 2017

18

1 reference

30 September 2017

3

1 reference

30 September 2017

305-322

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00813500

30 September 2017

0 references

cites work

Long-term follow-up of zidovudine therapy in asymptomatic HIV infection: results of a multicenter cohort study. The Italian Zidovudine Evaluation Group

1 reference

12 December 2020

AIDS as immune system activation: a model for pathogenesis.

1 reference

12 December 2020

Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis

1 reference

12 December 2020

Induction of expression of HIV in latently or chronically infected cells

1 reference

12 December 2020

Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS

1 reference

12 December 2020

CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine

1 reference

12 December 2020

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

1 reference

12 December 2020

Follicular dendritic cells productively infected with immunodeficiency viruses transmit infection to T cells

1 reference

12 December 2020

gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages

1 reference

12 December 2020

Cytokine modulation of HIV expression

1 reference

12 December 2020

NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection

1 reference

12 December 2020

Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection

1 reference

12 December 2020

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

1 reference

12 December 2020

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

12 December 2020

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

1 reference

12 December 2020

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

12 December 2020

Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.

1 reference

12 December 2020

Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens

1 reference

12 December 2020

Quantitative analysis of viral burden in tissues from adults and children with symptomatic human immunodeficiency virus type 1 infection assessed by polymerase chain reaction

1 reference

12 December 2020

HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy

1 reference

12 December 2020

HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis

1 reference

12 December 2020

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

1 reference

12 December 2020

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

12 December 2020

Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells

1 reference

12 December 2020

Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy

1 reference

12 December 2020

Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA.

1 reference

12 December 2020

Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes

1 reference

12 December 2020

The anatomy of T-cell activation and tolerance

1 reference

12 December 2020

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Lymphoid organs function as major reservoirs for human immunodeficiency virus

1 reference

12 December 2020

Systemic lymphadenopathic histology in human immunodeficiency virus-1-seropositive drug addicts without apparent acquired immunodeficiency syndrome

1 reference

12 December 2020

Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee

1 reference

12 December 2020

Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent.

1 reference

12 December 2020

Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection

1 reference

12 December 2020

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Progressive histopathologic abnormalities in the persistent generalized lymphadenopathy syndrome

1 reference

12 December 2020

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

1 reference

12 December 2020

Follicular dendritic cells retain HIV-1 particles on their plasma membrane, but are not productively infected in asymptomatic patients with follicular hyperplasia

1 reference

12 December 2020

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

1 reference

12 December 2020

Repression of MHC class I gene promoter activity by two-exon Tat of HIV

1 reference

12 December 2020

gp120 ligation of CD4 induces p56lck activation and TCR desensitization independent of TCR tyrosine phosphorylation

1 reference

12 December 2020

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

12 December 2020

Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes

1 reference

12 December 2020

Migration of so-called naive and memory T lymphocytes from blood to lymph in the rat. The influence of IFN-gamma on the circulation pattern.

1 reference

12 December 2020

Human immunodeficiency virus type 1 kinetics in lymph nodes compared with plasma

1 reference

12 December 2020

The human immunodeficiency virus: infectivity and mechanisms of pathogenesis

1 reference

12 December 2020

Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group

1 reference

12 December 2020

Spectrum of morphologic changes of lymph nodes from patients with AIDS or AIDS-related complexes.

1 reference

12 December 2020

Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures

1 reference

12 December 2020

Immunohistochemical demonstration of p24 HTLV III major core protein in different cell types within lymph nodes from patients with lymphadenopathy syndrome (LAS).

1 reference

12 December 2020

The initial immune response to HIV and immune system activation determine the outcome of HIV disease

1 reference

12 December 2020

Multifactorial nature of human immunodeficiency virus disease: implications for therapy

1 reference

12 December 2020

A controlled trial of zidovudine in primary human immunodeficiency virus infection

1 reference

12 December 2020

Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue

1 reference

12 December 2020

Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease

1 reference

12 December 2020

HIV-1 infection stimulates T cell invasiveness and synthesis of the 92-kDa type IV collagenase.

1 reference

12 December 2020

Follicular dendritic cells and human immunodeficiency virus infectivity

1 reference

12 December 2020

The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group

1 reference

12 December 2020

Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals

1 reference

12 December 2020

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

1 reference

12 December 2020

Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein

1 reference

12 December 2020

Dynamics of virus versus host interaction in children with human immunodeficiency virus type 1 infection

1 reference

12 December 2020

A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00813500

1 reference

30 September 2017

1 reference

PubMed ID

9089951